Get your full text copy in PDF
Co-targeting HER2/ErbB2 and insulin-like growth factor-1 receptors causes synergistic inhibition of growth in HER2-overexpressing breast cancer cells.
Anne Camirand, Yuhong Lu, Michael Pollak
Med Sci Monit 2002; 8(12): 521-526
Manuscript ID: 4817
If you dont have an access code, you can buy it for